Cytena secures €3M in funding to advance its single-cell technology
By Nikita Chaurasia  Date: 2019-03-27

Cytena secures €3M in funding to advance its single-cell technology
  • The capital will help to broaden the sales activities of Cytena and capitalize on new applications
  • Single-cells are used in the development of biopharmaceuticals and in stem cell and cancer research

Reports confirm that High-Tech Grunderfonds (HTGF) and two private investors are going to invest another 3 million euros in Cytena GmbH. This capital will be used in developing Cytena’s single-cell printer lab technology, broaden its sales activities and promptly tap into the capabilities of new applications.

Apparently, the two private investors and High-Tech Grunderfonds (HTGF) have confidence in the significance of isolation of single-cell for the development of biopharmaceuticals as well as for genetic analysis in diagnostics and research.

Benjamin Steimle, CFO of Cytena stated that the new capital would help to understand better and serve the customer’s requirements as well as help to increase the market share of the company.

Cytena mentioned that along with way, important milestones achieved include a collaboration in sales with a vital American company and addition of x.sight devices.

In recent years, the analysis of individual biological cells has gained its importance rapidly. These single-cells are used in the development of latest drugs called biopharmaceuticals and also in stem cell and cancer research, the firm said.

Cytena’s single cell printers comprise of laboratory devices for sorting and managing individual viable cells. These instruments are considered as one of the innovative platforms for life science and offer long-term contribution towards the manufacturing and development of new drugs.

According to HTGF Investment Manager, Dr. Lena Krzyzak, investment in the Series A round helps the company to continues its successful growth in start-up financing. Dr. Krzyzak said with the company is greatly confident in its management team’s ability to expand the market and product development.

For the uninitiated, Cytena is a well-known start-up in life sciences which was founded in 2014 at the University of Freiburg, by spinning off from the Institute for Microsystems Technology (IMTEK). The Cytena team has developed the technology called the single-cell printer which enables the isolation of single cells in a gentle, sterile and documented process.

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

WELL Health reveals plans to acquire Cycura’s services division
WELL Health reveals plans to acquire Cycura’s services division
By Nikita Chaurasia

  The acquisition would elevate WELL Health's cybersecurity program across the technology and healthcare sectors  WELL Health would build a strong portfolio of companies and products/services as part of its capital allocation initia...

Abry adds HealthEZ to its pool of healthcare service investments
Abry adds HealthEZ to its pool of healthcare service investments
By Nikita Chaurasia

Abry Partners, one of the most successful private equity investment firms in North America, has reportedly made it to the headlines for acquiring majority stake in a Minnesota-based third-party administrator of self-funded medical plans, HealthEZ. T...

Welltel acquires Kildare-based secure IT & cloud service provider Novi
Welltel acquires Kildare-based secure IT & cloud service provider Novi
By Nikita Chaurasia

Ireland-based end-to-end communication services provider, Welltel has recently announced the acquisition of Novi, a Kildare-based IT service firm. With the said acquisition the two companies would now be able to offer an integrated suite of secure co...

Canzon to explore German market by partnering with Lykos Verde
Canzon to explore German market by partnering with Lykos Verde
By Nikita Chaurasia

Canzon, an Israeli enterprise selling CBD-based products in Europe has reportedly entered a partnership worth NIS 6 million yearly with German distribution firm Lykos Verde. Sources close to the matter stated that as per the agreement, Lykos Verde w...

Société Générale purchases Shine to expand retail banking portfolio
Société Générale purchases Shine to expand retail banking portfolio
By Nikita Chaurasia

France-based multinational investment bank Société Générale S.A. has reportedly acquired Shine, a neobank for entrepreneurs, for an undisclosed sum. According to reliable sources, the acquisition will allow the financial s...